HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study. Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research.
In a Swiss multicenter study, a significant increase of HLA-DR4 was found in patients with rheumatoid arthritis when compared with normal controls (P less than 0.01). This increase was limited to patients with rheumatoid factors; it was strongest in patients with high titers. Similarly, the frequency of HLA-DR4 was higher in patients with larger amounts of circulating immune complexes when compared with patients with low amounts. No correlation with the presence of antinuclear antibodies was found. HLA-DR1 was more frequent in patients with rheumatoid arthritis than in controls (N.S.). This was due to an increase of HLA-DR1 in patients without rheumatoid factors (P less than 0.05), low amounts of circulating immune complexes (N.S.) and without antinuclear antibodies (P less than 0.05).
D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D000936:Antigen-Antibody Complex / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D012217:Rheumatoid Factor